Search

Your search keyword '"Ebrahimi, Mohammad"' showing total 3 results
Start Over Author "Ebrahimi, Mohammad" Search Limiters Full Text Publication Year Range Last 3 years Journal future microbiology
3 results on '"Ebrahimi, Mohammad"'

2. Prevalence of linezolid resistance in Streptococcus pneumoniaeisolates: a systematic review and meta-analysis

Author

Heidari, Mohsen, Dashtbin, Shirin, Asadi, Arezoo, Asadollahi, Parisa, Khatib, Ali, Ebrahimi, Mohammad Amin, Ghanbari, Zahra, Darbandi, Atieh, Ghanavati, Roya, and Pakzad, Reza

Abstract

Aim:This study aimed to understand the current level of linezolid (LNZ) resistance in Streptococcus pneumoniaeisolates reported over the past 10 years. Material & methods:An electronic search was conducted for the following keywords: ((Streptococcus pneumoniae[title/abstract]) OR (Pneumococcus[title/abstract]) OR (Pneumococci [title/abstract]) AND (linezolid [title/abstract]) OR (Zyvox [title/abstract])) OR (Zyvoxid [title/abstract])). Result:Out of all the studies, 80 had a cross-sectional design, while 11 followed a cohort approach. The prevalence of LNZ resistance among S. pneumoniaeisolates ranged from 0% to 4.86%. Discussion:Urgent, high-powered, randomized, controlled trials with participants from endemic regions are needed to gain a comprehensive understanding of the impact on and significance of LNZ treatment to patients.

Published
2024
Full Text
View/download PDF

3. Prevalence of linezolid resistance in Streptococcus pneumoniae isolates: a systematic review and meta-analysis.

Author

Heidary M, Dashtbin S, Asadi A, Asadollahi P, Khatib A, Ebrahimi MA, Ghanbari Z, Darbandi A, Ghanavati R, and Pakzad R

Abstract

Aim: This study aimed to understand the current level of linezolid (LNZ) resistance in Streptococcus pneumoniae isolates reported over the past 10 years. Material & methods: An electronic search was conducted for the following keywords: (( Streptococcus pneumoniae [title/abstract]) OR ( Pneumococcus [title/abstract]) OR (Pneumococci [title/abstract]) AND (linezolid [title/abstract]) OR (Zyvox [title/abstract])) OR (Zyvoxid [title/abstract])). Result: Out of all the studies, 80 had a cross-sectional design, while 11 followed a cohort approach. The prevalence of LNZ resistance among S. pneumoniae isolates ranged from 0% to 4.86%. Discussion: Urgent, high-powered, randomized, controlled trials with participants from endemic regions are needed to gain a comprehensive understanding of the impact on and significance of LNZ treatment to patients.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results